department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Fentora · pharmadog

pharmadog
drugs
Fentora

patient view

This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.

← back to professional view

drug

Effentora

Marketedupdated 2mo ago

by Teva Pharmaceuticals USA Inc

Approved

community read0 votes

all catalysts(88)

approval · 88

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

view all 88 catalysts →

News(0)

no news has mentioned this drug yet

brand

Fentora

generic

fentanyl citrate

indication

Cancer Pain

phase

marketed

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

FENTANYL CITRATE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

FENTANYL CITRATE — FDA approval

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 23, 2027

~1.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (18)

Jan 26, 2032formulationUS 9731869
Jan 26, 2032formulationUS 9731869
Jan 26, 2032formulationUS 9731869
Jun 15, 2028formulationUS 78628321.9y
Jun 15, 2028formulationUS 78628321.9y
Jun 15, 2028formulationUS 78628321.9y
Jun 15, 2028formulationUS 78628321.9y
Jun 15, 2028formulationUS 78628321.9y
Jun 15, 2028formulationUS 78628331.9y
Jun 15, 2028formulationUS 78628331.9y
Jun 15, 2028formulationUS 78628331.9y
Jun 15, 2028formulationUS 78628331.9y
Jun 15, 2028formulationUS 78628331.9y
Jul 23, 2027formulationUS 95972881.0y
Jul 23, 2027formulationUS 95972881.0y
Jul 23, 2027formulationUS 95972881.0y
Jul 23, 2027formulationUS 95972881.0y
Jul 23, 2027formulationUS 95972881.0y

Data sources

openFDA · ClinicalTrials.gov

last refreshed 55m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval368 co-mentions · 155 sources
drugActiq265 co-mentions · 183 sources
drugSUBLIMAZE PRESERVATIVE FREE263 co-mentions · 183 sources
drugFENTANYL-37234 co-mentions · 183 sources
drugfentanyl CR234 co-mentions · 183 sources
drugFENTANYL-75234 co-mentions · 183 sources
drugfentanyl234 co-mentions · 183 sources
drugfentanyl ER234 co-mentions · 183 sources

Trials studying Effentora

phase1A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumorsrecruitingn=100
phase3Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspneacompletedn=21